Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Interfascial Hydrodissection Added to Ultrasound-Guided Piriformis Injection in Piriformis Syndrome: A Prospective Randomized Controlled Trial

NCT07813455 is registered in ClinicalTrials.gov with Haydarpasa Numune Training and Research Hospital as lead sponsor.

NCT NCT07813455
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07813455 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Interfascial Hydrodissection Added to Ultrasound-Guided Piriformis Injection in Piriformis Syndrome: A Prospective Randomized Controlled Trial
Lead sponsor
Haydarpasa Numune Training and Research Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
September 24, 2026
Completion date
October 31, 2027
Enrollment
110 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

piriformis syndrome